Dilation Capital Management LP Buys 13,042 Shares of Celestica, Inc. $CLS

Dilation Capital Management LP increased its stake in shares of Celestica, Inc. (NYSE:CLS) (TSE:CLS) by 29.6% during the 4th quarter, HoldingsChannel.com reports. The fund owned 57,137 shares of the technology company’s stock after purchasing an additional 13,042 shares during the period. Celestica makes up approximately 7.8% of Dilation Capital Management LP’s holdings, making the stock its 3rd biggest holding. Dilation Capital Management LP’s holdings in Celestica were worth $16,890,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Pinney & Scofield Inc. lifted its position in Celestica by 20.0% during the 3rd quarter. Pinney & Scofield Inc. now owns 180 shares of the technology company’s stock worth $44,000 after acquiring an additional 30 shares in the last quarter. LeConte Wealth Management LLC raised its position in shares of Celestica by 3.5% in the 4th quarter. LeConte Wealth Management LLC now owns 1,001 shares of the technology company’s stock valued at $296,000 after purchasing an additional 34 shares in the last quarter. Terra Nova Asset Management LLC raised its position in shares of Celestica by 2.3% in the 4th quarter. Terra Nova Asset Management LLC now owns 1,686 shares of the technology company’s stock valued at $498,000 after purchasing an additional 38 shares in the last quarter. Oxinas Partners LLC raised its position in shares of Celestica by 1.4% in the 4th quarter. Oxinas Partners LLC now owns 2,958 shares of the technology company’s stock valued at $874,000 after purchasing an additional 40 shares in the last quarter. Finally, Avantax Planning Partners Inc. raised its position in shares of Celestica by 2.7% in the 4th quarter. Avantax Planning Partners Inc. now owns 1,528 shares of the technology company’s stock valued at $452,000 after purchasing an additional 40 shares in the last quarter. 67.38% of the stock is owned by institutional investors and hedge funds.

Celestica Stock Performance

CLS stock opened at $367.81 on Monday. The company has a current ratio of 1.26, a quick ratio of 0.73 and a debt-to-equity ratio of 0.36. The firm has a market cap of $42.29 billion, a P/E ratio of 44.47, a P/E/G ratio of 0.85 and a beta of 2.09. Celestica, Inc. has a 12-month low of $110.54 and a 12-month high of $435.00. The stock’s 50 day simple moving average is $341.10 and its 200 day simple moving average is $316.83.

Celestica (NYSE:CLS) (TSE:CLS) last posted its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.08. The business had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. Celestica had a return on equity of 36.91% and a net margin of 6.95%.The business’s revenue was up 52.8% compared to the same quarter last year. During the same period in the prior year, the company posted $1.20 EPS. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. As a group, equities research analysts predict that Celestica, Inc. will post 9.5 EPS for the current year.

Wall Street Analyst Weigh In

CLS has been the topic of a number of recent analyst reports. TD upped their target price on Celestica from $330.00 to $350.00 and gave the company a “hold” rating in a research report on Monday, April 20th. BMO Capital Markets upped their target price on Celestica from $370.00 to $450.00 and gave the company an “outperform” rating in a research report on Friday, April 24th. JPMorgan Chase & Co. upped their target price on Celestica from $410.00 to $425.00 and gave the company an “overweight” rating in a research report on Wednesday, April 29th. UBS Group upped their target price on Celestica from $355.00 to $400.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Finally, TD Cowen raised Celestica from a “hold” rating to a “buy” rating and upped their target price for the company from $350.00 to $430.00 in a research report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $427.42.

Insider Activity

In related news, Director Michael Max Wilson sold 4,168 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the sale, the director directly owned 24,718 shares of the company’s stock, valued at approximately $8,238,756.58. This represents a 14.43% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 1.10% of the company’s stock.

About Celestica

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.